By
Treatment Action Group
Published: March 22, 2014, 5:18 p.m.·
Tags:
Global TB response,
Advocacy
Research dollars drop just as old disease grows more difficult to treat.
Read More →
By
Médecins Sans Frontières
Published: March 22, 2014, 5:15 p.m.·
Tags:
Treatment,
Access,
Drug-resistant TB,
Advocacy
The ministry of health must act to stop drug resistance from spiralling.
Read More →
By
Médecins Sans Frontières
Published: March 22, 2014, 5:10 p.m.·
Tags:
Advocacy,
Global TB response,
Drug-resistant TB,
Treatment,
Global health
New MSF briefing paper outlines why deadly strains of DR-TB is one of the biggest global health threats we face today.
Read More →
By
UNAIDS
Published: March 22, 2014, 5:05 p.m.·
Tags:
Global TB response,
HIV coinfection,
Advocacy
UNAIDS is calling for an innovative, integrated effort to prevent HIV and TB - working together to increase resources and reach everyone living with HIV with key TB prevention interventions.
Read More →
By
UNITAID
Published: March 22, 2014, 5 p.m.·
Tags:
Global TB response,
Treatment,
Drug-resistant TB,
Advocacy
Until better medicines are introduced, multidrug-resistant tuberculosis will remain a dangerous global threat.
Read More →
By
AstraZeneca
Published: March 21, 2014, 5:57 p.m.·
Tags:
Advocacy,
Pharma industry,
Research and development
AstraZeneca's response to open letter expressing concern for its departure from tuberculosis and urging the company to ensure continued investment in the field.
Read More →
By
World Health Organization,
UNITAID,
FIND,
Stop TB Partnership
Published: March 20, 2014, 11 p.m.·
Tags:
Drug-resistant TB,
Diagnostics
Innovative project expands access to new test: the project known as EXPAND-TB helped to triple the number of MDR-TB cases diagnosed in participating countries.
Read More →
By
TB Europe Coalition
Published: March 20, 2014, 10:57 p.m.·
Tags:
Advocacy,
Global TB response,
Drug-resistant TB,
Public health
On World TB Day 2014, the TB Europe Coalition calls on EU institutions to recognise MDR-TB as a cross border health threat and to provide regional political leadership in the fight against MDR-TB in the European region.
Read More →
By
Theo Smart
Published: March 20, 2014, 10:50 a.m.·
Tags:
Treatment,
HIV coinfection,
Latent TB,
Drug-resistant TB,
Diagnostics,
Extrapulmonary TB,
Scientific research
With increased TB activism and research into new treatments, preventive therapies, and diagnostics, the space devoted to TB at CROI has increased substantially.
Read More →
By
Clinicians, advocacy groups, medical organizations
Published: March 19, 2014, 9:37 p.m.·
Tags:
Advocacy,
Pharma industry,
Compassionate use,
Treatment,
Access,
Drug-resistant TB
Leading doctors, advocacy groups and medical organizations remain concerned on several fronts regarding access to delamanid.
Read More →
Page 98 of 133 · Total posts: 10
←First
97
98
99
Last→